NCT03817580已完成3 期
Comparative Study of Antimicrobial Effectiveness Evaluation of 26 ml Project X, 5.1 ml Project X and Prevantics® Maxi Swabstick Following ASTM E1173
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 170
- 试验地点
- 1
- 主要终点
- Change in Bacterial Microflora on the Abdomen
研究概览
简要总结
Comparative Study of Antimicrobial Effectiveness Evaluation of 26 ml Project X, 5.1ml Project X and Prevantics® Maxi Swabstick following ASTM E1173 - Standard Test Method for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations, ASTM International, West Conshohocken, PA, 2015,
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
盲法说明
Samples are blinded to the participant and technical team.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male or female at least 18 years of age and of any race
- •In good general health
- •Read, understand and sign the Informed Consent Form (ICF)
- •If female of child-bearing potential, are willing to use an acceptable method of contraception to prevent pregnancy (i.e. oral contraceptive, intra-uterine device, diaphragm, condom, abstinence, bilateral tubal ligation, or are in a monogamous relationship with a partner who has had a vasectomy)
- •Female subjects of child-bearing potential, must have a negative Urine Pregnancy Test (UPT) on Treatment Day prior to any applications of the study products
- •Screening Day Baseline microbial counts are at least 3.11 colony forming units (CFU)/cm2 bilaterally from the skin of the abdomen, and 5.00 log10 colony forming units (CFU)/cm2 bilaterally from the skin of the groin (not applicable for Neutralization study)
排除标准
- •Exposure of test sites to antimicrobial agents, medicated soaps, medicated shampoos, or medicated lotions, use of biocide-treated pools or hot tubs, use of tanning beds, or sunbathing during the 14-day washout conditioning period and during the test period (7-day for Neutralization study)
- •Exposure of the test sites to strong detergents, solvents, or other irritants during the 14-day washout conditioning period and during the test period (7-day for Neutralization study)
- •Wear fabric softener, bug repellent or UV-treated clothing during the 14-day washout conditioning period and during the test period (7-day for Neutralization study)
- •Receive an irritation score of 1 (any redness, swelling, rash, or dryness present at any treatment area) for any individual skin condition prior to the Screening Day baseline or Treatment Day baseline sample collection or Neutralization study
- •Use of systemic or topical antibiotic medications, steroid medications (other than for hormonal contraception or post-menopausal reasons), or any other product known to affect the normal microbial flora of the skin during the 14-day washout conditioning period and during the test period (7-day for Neutralization study)
- •Known allergies or sensitivities to vinyl, latex (rubber), alcohols, metals, inks, or tape adhesives, or to common antibacterial agents found in soaps, lotions, or ointments, particularly isopropyl alcohol or chlorhexidine gluconate
- •A medical diagnosis of a physical condition, such as a current or recent severe illness, asthma, diabetes, hepatitis, an organ transplant, mitral valve prolapses, congenital heart disease, internal prostheses, or any immunocompromised conditions such as AIDS (or HIV positive)
- •Pregnancy, plans to become pregnant within the washout and test periods of the study, or nursing a child
- •Any tattoos or scars within 2" (5.08 cm) of the test sites
- •Dermatoses, cuts, lesions, active skin rashes, or breaks or other skin disorders within 6" on or around the test sites
- •A currently active skin disease or inflammatory skin condition (for example, contact dermatitis) anywhere on the body that, in the opinion of the Consulting Physician or PI, would compromise subject safety or study integrity
- •Showering, bathing, or swimming within the 72-hour period prior to sampling for baseline screening, Treatment Day, and throughout the test period (not applicable for Neutralization study)
- •Participation in another clinical study in the past 30 days or current participation in another clinical study at time of signing informed consent
- •Any medical condition or use of any medications that, in the opinion of the PI, should preclude participation
- •Unwillingness to fulfill the performance requirements of the study.
研究组 & 干预措施
Project X 26ml
Experimental
3.15 % w/v CHG (chlorhexidine gluconate) / 70% v/v IPA (isopropyl alcohol) contained within a saturated at use swabstick. 26ml volume. Single use.
干预措施: Project X 26ml (Drug)
Project X 5.1ml
Experimental
3.15 % w/v CHG (chlorhexidine gluconate) / 70% v/v IPA (isopropyl alcohol) contained within a saturated at use swabstick. 5.1ml volume. Single use.
干预措施: Project X 5.1ml (Drug)
Prevantics Maxi Swabstick
Active Comparator
3.15 % w/v CHG (chlorhexidine gluconate) / 70% v/v IPA (isopropyl alcohol). Swabstick. 5.1ml volume. Single use.
干预措施: Prevantics Maxi Swabstick (Drug)
结局指标
主要结局
Change in Bacterial Microflora on the Abdomen
时间窗: 6 hours
Bacterial microflora (log10) will be measured via cup scrub method after administration of the intervention
Change in Bacterial Microflora on the Inguinal Area
时间窗: 6 hours
Bacterial microflora (log10) will be measured via cup scrub method after administration of the intervention
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Pilot Evaluation of Two Test Materials With a Positive Control When Used as a Patient Preoperative Skin PreparationBacteria Microflora ReductionNCT03861780Professional Disposables International, Inc.152
已完成
不适用
Comparing antibacterial action and in between appointment pain of herbal irrigant versus 3% sodium hypochlorite as root canal irrigant in lower molars.CTRI/2022/10/046344Shreya Volety40
已完成
4 期
Comparing antibacterial action and in-between appointment pain of 3% sodium hypochlorite as root canal irrigant at different temperatures in necrotic teeth.CTRI/2024/06/068268Dr Shreya Volety45
招募中
3 期
Comparing the antibacterial efficacy of two different crowns in childreCTRI/2023/10/058361Datta Meghe Institute of Higher Education and Research
尚未招募
不适用
Comparative Evaluation Of Antimicrobial Efficacy Of Carica papaya leaf extract mouthwash, Probiotics mouthwash and Kidodent and placebo mouthwash in reducing salivary Streptococcus mutans count in 8-12 year old children. A Double blinded parallel designed Randomised Controlled StudyCTRI/2020/10/028699SYEDA SUBIA SARA